T, Z., P, Z., & HX, L. (2021). CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press.
Style de citation Chicago (17e éd.)T, Zhang, Zhang P, et Li HX. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.
Style de citation MLA (8e éd.)T, Zhang, et al. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.